Virtual Group Speech Therapy for Head and Neck Cancer

Recruiting at 1 trial location

Overseen By Houda Bahig, MD PhD

Age: 18+

Sex: Any

Trial Phase: Phase 1 & 2

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Disqualifiers: Metastases, Laryngectomy, Dysphagia, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Approved in 1 Jurisdiction This treatment is already approved in other countries

Compensation: Varies

Number of Visits: Unknown

76 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new kind of speech therapy for people with head and neck cancer. The therapy, called the Virtual Group Speech Pathology Intervention, occurs online in groups, guided by a patient who has undergone similar treatment. It aims to help patients adhere to their therapy and prevent swallowing problems that can arise after chemoradiotherapy. The trial seeks participants who have head or neck cancer, will receive specific radiation therapy, and speak French well enough to answer questions. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this innovative therapy.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.

What prior data suggests that this virtual group speech therapy intervention is safe for patients with head and neck cancer?

Research shows that specific safety information for virtual group speech therapy for head and neck cancer patients is not yet available. However, this therapy is generally considered low-risk.

Similar studies have successfully used telehealth methods, such as virtual group sessions, with cancer patients. For example, in the Netherlands, patients used touch screen computers to report their feelings without encountering major problems. This suggests that virtual methods can be effective and well-accepted by patients.

As this trial is in its early stages, it focuses on ensuring the treatment is safe and manageable, making serious side effects unlikely at this point. Overall, while specific safety data for this therapy is limited, virtual interventions in similar contexts have been well-received and considered safe. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about virtual group speech therapy for head and neck cancer because it offers a new way to deliver speech pathology care. Unlike traditional in-person sessions, this method uses virtual technology to connect patients in a group setting, guided by a patient partner. This approach not only makes therapy more accessible and convenient for patients who might struggle with travel or scheduling but also fosters a supportive community among participants. By leveraging digital platforms, this therapy has the potential to enhance engagement and improve outcomes for those recovering from head and neck cancer.

What evidence suggests that this virtual group speech therapy intervention is effective for head and neck cancer?

Research shows that online group speech therapy might benefit patients with head and neck cancer. In this trial, participants will join a virtual group speech therapy intervention led by a patient partner, simplifying participation. Past online health programs have successfully supported and educated cancer patients, suggesting this approach can help them adhere to treatment and avoid swallowing problems. Studies also indicate that online health services can improve access to care and increase patient understanding, potentially leading to better health outcomes. This could significantly enhance the quality of life for those undergoing chemoradiotherapy. ^{1 2 3 6 7}

Are You a Good Fit for This Trial?

Adults over 18 with head or neck cancer starting chemoradiotherapy for cure can join. They need a radiation dose of at least 60 Grays and must speak French well enough for questionnaires. Those with distant cancer spread, planned total laryngectomy, prior severe swallowing issues, another simultaneous cancer, previous head/neck radiation, or significant cognitive impairments cannot participate.

Inclusion Criteria

My radiation therapy is planned to be 60 Grays or more.

I am 18 or older with head or neck cancer.

I am scheduled for chemoradiotherapy aimed at curing my condition.

Exclusion Criteria

I have been diagnosed with another cancer at the same time as my current one.

I have had serious swallowing problems checked by a speech therapist.

I have had radiation therapy to my head or neck.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Chemoradiotherapy

Participants receive chemoradiotherapy treatment for head and neck cancer

6 weeks

Virtual Group Speech Therapy

Participants engage in a virtual, group-based speech therapy intervention guided by a patient partner

Concurrent with chemoradiotherapy

Follow-up

Participants are monitored for safety and effectiveness after treatment, including evaluation of nasogastric tube placement

6 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Virtual Group Speech Pathology Intervention

Trial Overview

The trial is testing the eG2 Intervention: a virtual group speech therapy guided by a patient partner to prevent swallowing difficulties in patients undergoing chemoradiotherapy for head and neck cancers. It aims to improve care quality and accessibility while optimizing healthcare resources.

How Is the Trial Designed?

Group I: virtual group speech therapy intervention guided by a patient partner Experimental Treatment 1 Intervention

Virtual Group Speech Pathology Intervention is already approved in Canada for the following indications:

Approved in Canada as eG2 Intervention for:

• Prevention of dysphagia in patients treated with chemoradiotherapy for head and neck cancer

Who Is Running the Clinical Trial?

Centre hospitalier de l'Université de Montréal (CHUM)

Lead Sponsor

Trials

389

Recruited

143,000+

Université du Québec à Trois-Rivières

Collaborator

Trials

48

Recruited

4,500+

Published Research Related to This Trial

In a study of 150 head and neck cancer patients over 12 months, better speech articulation was linked to a lower risk of dropout from the study, indicating that speech outcomes are crucial for patient retention.

Swallowing function did not show a significant relationship with dropout rates, suggesting that speech outcomes may be more critical in understanding patient experiences and the impact of surgical interventions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Relating speech and swallow function to dropout in a longitudinal study of head and neck cancer. Colangelo, LA., Logemann, JA., Rademaker, AW., et al.[2007]

The Electronic Patient Visit Assessment (ePVA) is a reliable and valid web-based tool that effectively captures patient-reported symptoms and functional limitations in individuals with head and neck cancer, demonstrating a high completion rate (92%) among participants.

The ePVA correlates significantly with health-related quality of life (HRQoL) scores, indicating that patients with more symptoms and limitations experience worse HRQoL, thus supporting its potential for real-time clinical interventions to improve patient outcomes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The usefulness of the Electronic Patient Visit Assessment (ePVA)© as a clinical support tool for real-time interventions in head and neck cancer. Van Cleave, JH., Fu, MR., Bennett, AV., et al.[2022]

A study of 128 non-laryngeal head and neck cancer survivors revealed that voice impairment is a common issue after treatment with radiotherapy (RT) or chemoradiotherapy (CRT), with significant findings of muscle tension and strain in the vocal cords.

The research highlighted that vocal handicap index (VHI) scores were significantly associated with dysphonia and treatment type, suggesting that targeted voice treatment regimens are needed to improve the quality of life for these patients.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Muscle Tension Dysphonia: A Sequeale of Chemoradiotherapy in Patients of Head and Neck Cancer. Sarin, V., Sarin, BC., Chatterjee, A., et al.[2023]

The shift to synchronous online clinical services for speech-language pathologists (SLPs) during the COVID-19 pandemic may lead to changes in vocal behaviors that could negatively affect voice production.

To prevent phonogenic voice problems, SLPs are encouraged to adopt new strategies for maintaining vocal health while delivering services online, guided by injury prevention frameworks.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Phonogenic Voice Problems among Speech-Language Pathologists in Synchronous Telepractice: An Overview and Recommendations. Knickerbocker, K., Bryan, C., Ziegler, A.[2021]

A study involving 187 patients showed that both individual and group voice therapy significantly improved self-perceived voice function over a year, with moderate to large effect sizes based on the Swedish Voice Handicap Index (VHI-11).

The most common reason for patients not attending recommended voice therapy was lack of time, highlighting a potential barrier to accessing these effective treatments.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Effects of Voice Therapy: A Comparison Between Individual and Group Therapy. Abrahamsson, M., Millgård, M., Havstam, C., et al.[2018]

The study evaluated a new telepractice service for speech pathology in managing swallowing and communication for head and neck cancer patients, involving 82 referrals across three sites.

Results showed that the telepractice model significantly improved service efficiency, reducing both the number and duration of contact events, while also increasing satisfaction for both patients and clinicians.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: Evaluation of service outcomes. Burns, CL., Ward, EC., Hill, AJ., et al.[2022]

A study involving 77 patients with functional voice disorders found that both individual and group voice therapy led to significant long-term improvements in voice quality and reduced voice-related handicap, as measured by the Voice Handicap Index (VHI) and other assessments.

Group therapy showed greater benefits over individual therapy, particularly in the physical aspects of voice handicap, suggesting that the group setting may enhance the application of voice techniques in everyday communication.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Voice Therapy Outcome-A Randomized Clinical Trial Comparing Individual Voice Therapy, Therapy in Group, and Controls Without Therapy. Ohlsson, AC., Dotevall, H., Gustavsson, I., et al.[2021]

A prospective database has been established in Melbourne, Australia, to track functional outcomes related to speech, swallowing, and voice in head and neck cancer patients, involving collaboration from eight hospitals and ongoing data collection since April 1997.

The early results from this database, after 12 months of data collection, highlight its potential for clinically-based research and benchmarking outcomes, although challenges in long-term data accuracy for this patient population are acknowledged.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Evaluation of functional outcomes (speech, swallowing and voice) in patients attending speech pathology after head and neck cancer treatment(s): development of a multi-centre database. Perry, AR., Shaw, MA.[2019]

The study involved 67 head and neck cancer patients and found that many experienced speech and swallowing problems, which significantly impacted their quality of life and emotional well-being.

Using the OncoQuest computerized monitoring system in an outpatient clinic proved feasible for tracking these issues, highlighting the importance of ongoing assessment in managing patient outcomes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practice. Cnossen, IC., de Bree, R., Rinkel, RN., et al.[2021]

This study analyzed functional outcomes in 293 head and neck cancer patients treated in Victoria, Australia, providing valuable data on speech, swallowing, and quality of life after treatment.

The findings suggest that optimal recovery of function typically occurs around six months post-treatment, establishing a reference point for future comparisons in similar patient populations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

An evaluation of functional outcomes (speech, swallowing) in patients attending speech pathology after head and neck cancer treatment(s): results and analysis at 12 months post-intervention. Perry, AR., Shaw, MA., Cotton, S.[2006]

Telepractice models, including asynchronous applications and videoconferencing, can significantly improve access to speech language pathology (SLP) services for patients with head and neck cancer, enhancing management of swallowing and communication disorders.

Patient and clinician satisfaction with these telepractice models is high, indicating their potential effectiveness, but further research is needed to evaluate large-scale implementation and economic impacts.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Application of telepractice for head and neck cancer management: a review of speech language pathology service models. Ward, EC., Wall, LR., Burns, CL., et al.[2018]

The online delivery of the Lee Silverman Voice Treatment (LSVT) for a patient with Parkinson's disease resulted in significant improvements in vocal sound pressure levels and speech intelligibility, demonstrating its efficacy.

The patient expressed high satisfaction with the online treatment format and preferred it over traditional face-to-face sessions, indicating that remote delivery of LSVT is both feasible and effective.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Home-based speech treatment for Parkinson's disease delivered remotely: a case report. Constantinescu, GA., Theodoros, DG., Russell, TG., et al.[2022]

In a 3-month pilot clinic involving 218 patients with head and neck cancer, Speech and Language Therapists (SLTs) effectively conducted assessments and treatment planning, demonstrating a safe collaboration with otolaryngologists.

The clinic identified a low cancer diagnostic yield of 5%, but found that higher scores on voice assessments (GRBAS) and patient-reported outcomes (VHI-10) were associated with a greater risk of serious diagnoses, suggesting these measures could help in identifying patients needing further evaluation.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Outcomes of an Advanced Speech and Language Therapist-Led Low-Risk 2-Week Wait Clinic for Suspected Head and Neck Cancer: A UK-Based Pilot Study. Butler, J., Sellstrom, D., Eastwood, N., et al.[2023]

A study involving 11 speech pathology staff from two regional/remote services identified 30 actionable goals to improve speech pathology services for head and neck cancer patients, focusing on enhancing access and delivery in rural areas.

The most critical area for change highlighted was the need for increased support in training, mentoring, and supervision, which is essential for consolidating skills among speech pathology professionals.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Speech pathology service enhancement for people with head and neck cancer living in rural areas: Using a concept mapping approach to inform service change. Foley, J., Ward, EC., Burns, CL., et al.[2021]

Citations

1.

clinicaltrials.gov

clinicaltrials.gov/study/NCT05621889

Innovative Patient-partner-guided Virtual Group Speech ...

The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a ...

2.

withpower.com

withpower.com/trial/phase-2-head-and-neck-neoplasms-2023-afce9

Virtual Group Speech Therapy for Head and Neck Cancer

This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de ...

3.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC2811073/

Development of a Telehealth Intervention for Head and Neck ...

This telehealth intervention provides support and education to patients undergoing treatment for head and neck cancers.

4.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC3074232/

Feasibility and Acceptance of a Telehealth Intervention to ...

Touch screen computers were successfully used in the Netherlands to collect quality of life and distress data from head and neck cancer patients [16].

5.

sciencedirect.com

sciencedirect.com/science/article/abs/pii/S1368837524000642

Role of telemedicine in head neck cancer

Telehealth interventions represent a possible novel approach to increase access to care across the cancer continuum, strengthen patients' knowledge and self- ...

6.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC11646266/

Telemedicine and Virtual Interventions in Cancer ...

The purpose of this review is to provide an overview of the practical applications of comprehensive cancer rehabilitation services through ...

7.

anzctr.org.au

anzctr.org.au/ACTRN12625001093471.aspx

ANZCTR - Registration

The purpose of this research is to test the effectiveness of using a computer simulation to personalise the force recommendations for jaw stretching and ...